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Abstract
Background. Previous research has shown an association between subjective wellbeing and
incident diabetes. Less is known about the role of wellbeing for subclinical disease trajectories
as captured via glycated hemoglobin (HbA1c). We aimed to explore the association between
subjective wellbeing and future HbA1c levels, and the role of sociodemographic, behavioral
and clinical factors in this association.
Methods. We used data from the English Longitudinal Study of Ageing for this study (N =
2161). Subjective wellbeing (CASP-19) was measured at wave 2 and HbA1c was measured
8 years later at wave 6. Participants were free from diabetes at baseline. We conducted a series
of analyses to examine the extent to which the association was accounted for by a range of
sociodemographic, behavioral and clinical factors in linear regression models.
Results. Models showed that subjective wellbeing (CASP-19 total score) was inversely asso-
ciated with HbA1c 8 years later after controlling for depressive symptoms, age, sex, and base-
line HbA1c (B =−0.035, 95% CI −0.060 to –0.011, p = 0.005). Inclusion of sociodemographic
variables and behavioral factors in models accounted for a large proportion (17.0% and 24.5%,
respectively) of the relationship between wellbeing and later HbA1c; clinical risk factors
explained a smaller proportion of the relationship (3.4%).
Conclusions. Poorer subjective wellbeing is associated with greater HbA1c over 8 years of fol-
low-up and this relationship can in part be explained by sociodemographic, behavioral and
clinical factors among older adults.
Introduction
It has been estimated that a large proportion of patients (18.5%) with type 2 diabetes remain
undiagnosed (Pierce et al., 2009). Type 2 diabetes develops gradually, and at early stages may
not have perceptible hyperglycemia-related symptoms (e.g. thirst, fatigue). When glucose levels
do not meet the criteria for the formal diagnosis of diabetes, but are beyond normal levels,
individuals face an increased risk of subsequent development of type 2 diabetes. Therefore,
this so-called ‘prediabetes’ stage encompasses individuals who have impaired glucose para-
meters within a specific, diabetes high-risk, range. Glycated hemoglobin (HbA1c) reflects
the average plasma glucose level within an individual over the previous 8–12 weeks. In recent
years, there has been a move toward HbA1c being used as a diagnostic test for type 2 diabetes
and as a screening test for those at high risk of type 2 diabetes (The International Expert
Committee, 2009).
HbA1c levels are strongly associated with age, even among those without clinically diag-
nosed diabetes. For example, findings from a large-scale epidemiological study using data
from the Framingham Offspring Study and the US National Health and Nutrition
Examination Study (NHANES) revealed a 0.014% and 0.010% increase in HbA1c levels per
year increase in age in each of these studies respectively; and the association remained after
taking into account sex, body mass index (BMI), fasting glucose and 2 h post-load glucose
values (Pani et al., 2008). While we know older individuals are more likely to have higher
HbA1c levels, what is less understood is the role of modifiable risk factors in HbA1c levels
over time, including the role of psychological factors.
A large body of evidence indicates that depression (from depressive symptoms to clinical
depression) predicts new-onset type 2 diabetes. Results from three meta-analyses of longitu-
dinal studies have shown an increased risk of type 2 diabetes among depressed individuals
compared with controls, respectively (Knol et al., 2006; Mezuk et al., 2008; Rotella and
Mannucci, 2013). Less is known about the effect of positive aspects of affect over and above
the deleterious effects of depression for type 2 diabetes risk.
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Subjective wellbeing is usually conceived as comprising two dis-
tinct domains: hedonic and eudemonic wellbeing. The former refers
to the experience of positive emotions such as feelings of happiness
or pleasure while the latter refers to the satisfaction of basic psycho-
logical needs and self-realization or sense of autonomy
[Organisation for Economic Co-operation and Development
(OECD), 2013]. A recent investigation of wellbeing found an inde-
pendent association between greater wellbeing and a lower rate of
onset of several chronic illnesses including an association, in those
younger, but not older, than 65 years, with incident diabetes
(Okely and Gale, 2016). Another study using data from the
Whitehall II cohort found that life satisfaction and emotional vital-
ity, but not optimism, were associated with reduced risk of
physician-diagnosed diabetes (Boehm et al., 2015). Data from ana-
lyses using over 48 000 participants taking part in the European
Prospective Investigation into Cancer and Nutrition (EPIC) Study,
showed that life satisfaction in women, but not men, was associated
with incident type 2 diabetes over 8 years (Feller et al., 2013).
However, what is unclear is the extent to which positive well-
being exerts an independent effect on diabetes onset, or the extent
to which it can be explained by other factors. Sociodemographic
factors such as wealth, employment grade and socioeconomic
position have been associated with both diabetes onset (Jaffiol
et al., 2013) and diabetes-related mortality (Jackson et al.,
2012), with findings consistent with a social gradient to health.
Health behaviors such as physical activity, present another pos-
sible pathway through which wellbeing affects diabetes risk. We
know that lower wellbeing has long been associated with reduced
engagement in physical activity (Fox, 1999). Time spent watching
television (a proxy measure for sedentariness) has been associated
with diabetes risk 2 years later (Smith and Hamer, 2014); more-
over sedentariness has been associated with increased risk of obes-
ity and type 2 diabetes (Hu et al., 2003) demonstrating the
cumulative effect of negative health behaviors on diabetes inci-
dence. Other health-related behaviors such as smoking and alco-
hol intake are also associated with reduced wellbeing (Shahab and
West, 2012; Geiger and MacKerron, 2016) and diabetes risk
(Koppes et al., 2005; Willi et al., 2007).
Chronic microvascular and macrovascular complications are
highly prevalent among those with hyperglycemia (Fowler, 2008).
Results from a meta-analysis of 102 studies showed that people
with diabetes have a twofold excess risk of cardiovascular disease
(CVD) compared to those without diabetes (Emerging Risk
Factors Collaboration et al., 2010). Moreover, CVD has a strong
inverse association with wellbeing (Boehm and Kubzansky, 2012).
Our understanding of the temporal nature between wellbeing
and diabetes risk would be increased by demonstrating an associ-
ation with HbA1c trajectories over time. We proposed to study
the effect of subjective wellbeing, independent of depressive
symptoms, on HbA1c levels measured over 8 years of follow-up,
in a population of older adults drawn from the English
Longitudinal Study of Ageing (ELSA). We hypothesized that
higher wellbeing would be associated with lower levels of
HbA1c over time and that these effects would be in part explained
by sociodemographic, behavioral and clinical risk factors.
Methods
Sample and study design
This study uses data from ELSA, a nationally representative general
population study of adults aged 50 years and older living in
England. Further details have been published in-depth previously
(Steptoe et al., 2013). In brief, the sample has been followed up
every 2 years from 2002 onwards, with refresher samples being
added at waves 3, 4, and 6. At every wave, participants complete
a computer-assisted personal interview plus a self-completion ques-
tionnaire. On alternate waves, a nurse visit is conducted to allow for
the collection of blood samples and objective assessments of phys-
ical function, such as BMI. Nurse visits are only conducted on core
sample members who have an interview in person.
This current paper reports data spanning 8 years, from wave 2
(2004/5) through to wave 6 (2012/2013), of core members with
nurse visit data at waves 2, 4, and 6. Wave 2 was selected as base-
line since this was the first point at which nurse data were col-
lected; 8780 core members participated at this wave. Wave 8 is
the most recently completed phase of data collection; however,
funding restrictions meant nurse visits were conducted on a sub-
stantially reduced sample of participants at this wave (∼50%).
Therefore, our main analyses are conducted using data from
waves 2 and 6. Compared to those excluded from our main ana-
lyses, those included were more likely to have a lower BMI, be
more physically active, drink alcohol more regularly and be
from a wealthier and white ethnic background; and less likely to
have a cohabiting partner and smoke (all p < 0.001). Complete
case analysis was performed on a sample of 2161 participants
(62.70 ± 7.55 years; 55.8% female) who provided data on all
exposure and outcome variables and covariates. A flow diagram
of how the sample size was derived is provided in Fig. 1.
Importantly, participants were excluded from the analyses if
they self-reported diabetes/high blood sugar at baseline, or if
their baseline HbA1c value was >48 mmol/mol (6.5%) which
would indicate possible undiagnosed diabetes (World Health
Organization, 2011).
Measures
Affect measures – exposure variables
Subjective wellbeing was measured using the CASP-19. The
CASP-19 was developed and validated to measure overall well-
being in older adults, across four different domains: control,
autonomy, self-realization, and pleasure (Hyde et al., 2003). The
CASP-19 requires participants to indicate how often each state-
ment applies to them on a four-point Likert scale ranging from
0 (often) to 3 (never). Responses are summed to give a total
score (range 0–57), with higher scores indicating better wellbeing
(Hyde et al., 2003). Scores for each of the four subscales were also
derived, with a score range of 0–12 for control and 0–15 for
autonomy, self-realization, and pleasure. The scale had good
internal consistency in our study (Cronbach’s α = 0.87).
Depressive symptoms were measured at baseline using the
eight-item Centre for Epidemiological Studies Depression
(CES-D) scale. The CES-D measures symptoms that can be
used to identify people at risk of depression, rather than clinical
depression per se (Radloff, 1977). The psychometric properties
of the eight-item version have been shown to be comparable to
the original 20-item version (Steffick, 2000). We computed a
summary score by adding responses to all eight dichotomous
questions (possible range: 0–8). The Cronbach’s α for the
CES-D in this study was 0.79.
HbA1c – outcome variable
HbA1c was assessed from blood drawn from participants’ fore-
arms during the nurse visits at waves 2, 4, and 6. Participants
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who had a clotting or bleeding disorder and those on anti-
coagulant medication did not provide blood samples. Fasting
samples, defined as not eating or drinking for 5 h prior to
blood draw, were collected where possible and when not other-
wise contraindicated (e.g. >80 years, known diabetes, frail or
unwell, ever had a seizure). All blood samples were analyzed at
the Royal Victoria Infirmary laboratory in Newcastle upon
Tyne, UK. A detailed description of blood analyses is available
elsewhere (Sproston and Mindell, 2004). HbA1c values are pre-
sented as the International Federation of Clinical Chemistry
units (mmol/mol) with Diabetes Control and Complication
Trial units measured in % provided in parentheses.
Other measures – covariates
Covariates were all measured at baseline (wave 2) and included
age, sex, and whether participants were married or cohabiting
with a partner. Socioeconomic status was included in models as
quintiles of net financial wealth, which refers to participants’
gross financial wealth with financial debt subtracted; wealth has
been found to be the best marker of socioeconomic status in
ELSA rather than education, which is a rather distal marker in
this age group (Demakakos et al., 2016). Ethnicity was coded as
a binary variable (white/non-white). Height and weight were col-
lected during the nurse visit and BMI was derived using the
standard formula (kg/m2). Whether or not participants reported
being a current smoker (no/yes) and the frequency of alcohol con-
sumption (</⩾3 times per week) were also included in models.
Participants reported the frequency in which they engaged in vig-
orous, moderate, and mild physical activity (more than once a
week, once a week, one to three times a month, hardly ever/
never) and we used these data to derive three possible categories
reflecting regularity of physical activity: no or only light physical
activity per week, moderate/vigorous activity once a week or less,
moderate/vigorous activity more than once a week. Clinical infor-
mation relating to cardiac health was also considered in models
and included self-reported coronary heart disease (CHD) com-
prising all positive reports of myocardial infarction and angina
(no/yes), stroke (no/yes), and use of β-blocker medications (no/
yes). Doctor diagnosis of hypertension and use of anti-
hypertensive medication was self-reported and these responses
were combined with objective assessments taken at the nurse
visit (hypertension defined as systolic blood pressure >140 and
diastolic blood pressure >90) to generate a binary variable (no/
yes).
Data on participants’ use of diabetes medication (insulin and/
or oral hypoglycemic) were collected at the wave 6 nurse visit; we
combined responses on these variables to create a binary variable
(no/yes) to represent the use of any diabetes medication.
Statistical analysis
Associations between variables were assessed using Pearson’s cor-
relations for continuous data and independent t tests, χ2 tests and
repeated-measures analysis of variance for categorical data, as
appropriate. Skewness and kurtosis values were within the accept-
able range for all variables, and multicollinearity, assessed by
examining variance inflation factors, was not apparent in any of
the statistical models performed. Linear regression models were
used to examine the effects of baseline (wave 2, i.e. 2004/5) sub-
jective wellbeing scores (CASP-19) on HbA1c at wave 6 (2012/
2013). Covariates were selected based on a priori knowledge
and included depressive symptoms (CES-D), age, sex, cohabit-
ation status, wealth, ethnicity, BMI, smoking, regularity of alcohol
consumption regularity of physical activity, CHD, stroke, hyper-
tension, and β-blockers. Depressive symptoms (CES-D) were
included in all models so as to allow us to assess the independent
effect of positive affect [i.e. wellbeing (CASP-19 scores)] over and
above negative affect (i.e. CES-D scores). Five separate models are
presented following adjustments: (1) adjusted for depressive
symptoms, age, sex, and baseline HbA1c; (2) adjusted for model
1 + wealth, ethnicity, and cohabitation; (3) adjusted for model
1 + BMI, alcohol consumption, smoking status, and physical
activity; (4) adjusted for model 1 + CHD, stroke, hypertension,
and β-blockers; (5) fully adjusted. Separate analyses were per-
formed in order to examine the change in the standardized β
coefficient for the CASP-19 with the addition of the covariates;
this approach makes no assumptions about the order in which
covariates are entered as with a hierarchical model. Data are pre-
sented as unstandardized β coefficients (B) and 95% confidence
intervals (CI), standardized β, and percentage change estimates
for the β values for the CASP-19. Two secondary analyses were
performed. First, we examined the age interaction effect described
by Okely and Gale (2016) by including a mean-centered inter-
action term for wellbeing and age in our fully adjusted model.
Fig. 1. Flow diagram of sample size. ELSA, English Longitudinal Study of Ageing.
*Self-reported diabetes/high blood sugar at baseline, or baseline HbA1c >6.5%
(48 mmol/mol).
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Contrary to findings by Feller et al. (2013), we found no evidence
for a sex by wellbeing interaction effect in our study (B = 0.071,
p = 0.502), so these models are not reported here. Second, we
examined the contribution of each of the four subscales of the
CASP-19 to the model; we entered wave 2 control, autonomy,
self-realization, and pleasure scales simultaneously into basic
and fully adjusted models to predict wave 6 HbA1c.
In sensitivity analyses exploring the cumulative effect of
HbA1c over time, we computed the mean HbA1c across the
follow-up waves of data collection (i.e. waves 4–6) for use as the
dependent variable, adjusting for all covariates. These analyses
report a larger sample size (N = 2907) since we included partici-
pants who provided a valid HbA1c result at either wave to calcu-
late the mean. We also performed sensitivity analyses removing
the participants who reported taking diabetes medications at
wave 6 (n = 45). These data were analyzed using linear regressions.
For illustrative purposes, CASP-19 scores were divided into
low and high categories using the median score of 46. HbA1c
values were plotted on a line graph to reflect the change in values
over time for low and high wellbeing groups according to baseline
CASP-19. All analyses were conducted using SPSS version 21. The
significance level was set at p < 0.05, though exact significance
levels are reported throughout.
Results
Table 1 shows the sociodemographic, behavioral, clinical and bio-
logical characteristics of the sample. On average, the sample was
aged 62.70 ± 7.55 years and just over half were female (55.8%).
The large majority of the sample were of white ethnic origin
(99.2%) and were married or cohabiting (76.2%). The mean
BMI of the sample was 27.44 kg/m2, which falls within the over-
weight range according to the UK National Health Service (NHS)
guidelines (NHS Choices, 2018). There was a significant inverse
correlation between depressive symptoms and subjective well-
being (r = −0.512, p < 0.001); overall mean depressive symptoms
were low while wellbeing was high. Univariate associations
between baseline wellbeing and HbA1c at 8-year follow-up
showed a significant inverse association (r =−0.073, p = 0.001),
but there was no association between baseline depressive symp-
toms and later HbA1c (r = 0.035, p = 0.105). Table 1 also displays
the p values for all other univariate associations between baseline
wellbeing and participant characteristics. There was an increase in
HbA1c levels over time (waves 2, 4, 6) which reached significance
(F = 28.112, p < 0.001) (illustrated in Fig. 2); overall HbA1c
increased from 35.59 mmol/mol (5.40%) to 40.05 mmol/mol
(5.81%) over time.
The association between wellbeing and HbA1c over time
Table 2 shows the results from our main analysis examining the
association between baseline wellbeing (2004/5) and HbA1c levels
8 years later at wave 6 (2012/13). Results in Table 2 show the asso-
ciation between CASP-19 and later HbA1c following basic adjust-
ment for depressive symptoms, age, sex, and baseline HbA1c,
supporting a significant inverse association (B =−0.035, 95% CI
−0.060 to −0.011, p = 0.005). These findings indicate that for a
1-point increase in the CASP-19, HbA1c scores reduced by
0.035 mmol/mol. Interestingly, depressive symptoms were also
inversely associated with later HbA1c in this model (B =−0.116,
95% CI −0.230 to −0.002, p = 0.046). Subsequent models adjusted
for other factors which might account for the excess risk
associated with lower wellbeing (see Table 3; furthermore, online
Supplementary Tables S1–S4 display the results for each of these
models in full). Sociodemographic variables (wealth, ethnicity,
cohabitation) accounted for a 17.0% reduction in the β for the
CASP-19 compared with the basic model. In particular, wealth
was significantly inversely associated with future HbA1c in this
model (B = −0.160, 95% CI −0.290 to −0.031, p = 0.015) (see
online Supplementary Table S1). Inclusion of behavioral factors
including BMI, alcohol, smoking and physical activity led to a
reduction in the β for CASP-19; these factors reduced the β by
24.5%. In this model, greater BMI (B = 0.074, 95% CI 0.036 to
0.113, p < 0.001), less regular alcohol consumption (B =−0.406,
95% CI −0.752 to −0.059, p = 0.022), and physical inactivity
(B =−0.390, 95% CI −0.633 to −0.147, p = 0.002) were all predic-
tors of future HbA1c (see online Supplementary Table S2). The
clinical model (CHD, stroke, hypertension, β-blockers) accounted
for a 3.4% reduction in the β for the CASP-19 compared with the
basic model; with none of the cardiac-related risk factors
significantly associated with future HbA1c levels (see online
Supplementary Table S3). In the final, fully adjusted model includ-
ing all covariates, the association was reduced (B =−0.024, 95% CI
−0.049 to 0.001, p = 0.064), with the sociodemographic, behavioral,
and clinical factors combined accounting for a 32.1% reduction in
the β for the CASP-19 compared with the basic model (see online
Supplementary Table S4).
In secondary analyses, we examined the evidence for an age
interaction effect. The interaction between wellbeing and age
was a significant predictor of wave 6 HbA1c (B = 0.003, 95% CI
0.001 to 0.006, p = 0.014) in the fully adjusted model adjusting
for CES-D, age, sex, wealth, ethnicity, cohabitation, baseline
HbA1c, BMI, alcohol, smoking, physical activity, CHD, stroke,
hypertension, and β-blockers. To explore this effect further we
split the data by age using a cut-off of 65 years. We ran our
fully adjusted model once more and found that wellbeing was
significantly associated with wave 6 HbA1c in those <65 years
(n = 1452) (B = −0.048, 95% CI −0.081 to −0.015, p = 0.004)
but not in those >65 years (n = 709) (B = 0.019, 95% CI −0.019
to −0.057, p = 0.320) in models adjusting for all covariates.
In another secondary analysis, we entered each of the four
CASP-19 subscales simultaneously into models to predict future
HbA1c. In basic models, only the autonomy subscale was signifi-
cantly associated with later HbA1c (B =−0.114, 95% CI −0.200
to −0.028, p = 0.009), but not control (B = 0.017, 95% CI
−0.086 to 0.120, p = 0.744), pleasure (B = −0.028 95% CI
−0.135 to 0.079, p = 0.611) or self-realization (B =−0.012, 95%
CI −0.100 to 0.077, p = 0.795). As with models using the total
CASP-19 score, none of the individual subscales were significant
predictors in fully adjusted models.
Sensitivity analyses
Sensitivity analyses were conducted using continuous CASP-19
scores as the predictor variable and the mean HbA1c value across
the length of follow-up (wave 4 and/or 6). Results revealed the
same pattern of findings. The inclusion of wave 4 HbA1c data
in these analyses increased the sample size to 2907 participants.
Results in basic models showed CASP-19 scores at baseline to
be inversely associated with mean HbA1c level over time, such
that higher wellbeing scores were associated with a lower mean
HbA1c in basic models controlling for depressive symptoms,
age, sex, and baseline HbA1c (B =−0.026, 95% CI −0.043 to
−0.008, p = 0.004). In fully adjusted models, baseline CASP-19
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scores were no longer a significant predictor of future HbA1c
(B =−0.015, 95% CI −0.033 to 0.003, p = 0.106).
Sensitivity analyses were also performed by repeating the mod-
els with the participants who were taking diabetes medication
(insulin and/or oral hypoglycemic) in wave 6 (n = 45) excluded.
In these analyses, the sample size was reduced to 2116. Fully
adjusted models adjusting for CES-D, age, sex, wealth, ethnicity,
cohabitation, baseline HbA1c, BMI, alcohol, smoking, physical
activity, CHD, stroke, hypertension, and β-blockers revealed a
similar pattern of results with wellbeing significant in basic mod-
els (B =−0.023, 95% CI −0.045 to −0.001, p = 0.039) with
associations attenuated after full adjustment for covariates
(B =−0.018, 95% CI −0.041 to 0.005, p = 0.123).
Discussion
This study looked at the longitudinal association between subject-
ive wellbeing and HbA1c up to 8 years later using nationally rep-
resentative data from England (ELSA) in individuals free from
diabetes at baseline. Our results were supportive of the hypothesis
that wellbeing plays an important role in glucose metabolism and
underlying diabetes pathology. Moreover, our results revealed that
Table 1. Demographic, clinical, and biological characteristics of the sample and their associations with baseline wellbeing (N = 2161)
Characteristic Mean ± S.D. or N (%) Test statistica p
Baseline sociodemographics
Age 62.70 ± 7.55 r =−0.03 0.116
Female 1205 (55.8) t =−0.19 0.846
Ethnicity (% white) 2143 (99.2) t = 0.55 0.585
Cohabiting 1646 (76.2) t = 6.08 <0.001
Net financial wealth – quintiles F = 44.10 <0.001
1 282 (13.0)
2 286 (13.2)
3 435 (20.1)
4 541 (25.0)
5 617 (28.6)
Baseline health and health behavior
Current smoker 274 (12.7) t = 5.30 <0.001
Regular physical activity F = 34.40 <0.001
None/only light 260 (12.0)
Moderate/vigorous sessions ⩽1 a week 546 (25.3)
Moderate/vigorous sessions >1 a week 1355 (62.7)
Regular alcohol drinker (⩾3 days/week) 913 (42.2) t =−6.17 <0.001
BMI (kg/m2) 27.44 ± 4.44 r =−0.06 0.003
Coronary disease (% yes) 140 (6.5) t = 2.77 0.006
Stroke (% yes) 41 (1.9) t = 4.25 <0.001
Hypertension (% yes) 797 (36.9) t = 2.94 0.003
β blockers (% yes) 3 (0.1) t =−0.45 0.653
Wave 6 medication
Diabetes medication (% yes) 45 (2.1) t = 2.68 0.008
Baseline mood
CES-D score (depressive symptoms) 1.21 ± 1.75 r =−0.51 <0.001
CASP-19 score (wellbeing) 44.25 ± 8.02 – –
Biomarkers
Wave 2 HbA1c [mmol/mol (%)] 35.59 ± 3.71 (5.40 ± 0.34) r =−0.06 0.006
Wave 4 HbA1cb [mmol/mol (%)] 39.32 ± 4.22 (5.75 ± 0.38) r =−0.07 0.003
Wave 6 HbA1c [mmol/mol (%)] 40.05 ± 5.36 (5.81 ± 0.49) r =−0.07 0.001
BMI, body mass index; CES-D, Center for Epidemiological Studies Depression (CES-D) scale; HbA1c, glycated hemoglobin.
aUnivariate relationship with baseline CASP-19; r for continuous variables, t or F for categorical variables.
bN = 1744.
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the direct effect of wellbeing on HbA1c could in part be attributed
to sociodemographic, behavioral, and clinical factors.
Sociodemographic factors accounted for 17.0% of the association
between wellbeing and HbA1c, behavioral factors explained 24.5%
of the association, while clinical factors relating to cardiovascular
health only accounted for 3.4% of the association. Our findings
were upheld in sensitivity analyses taking into account wave 4
HbA1c data and wave 6 diabetes medications. These findings
are the first to our knowledge to assess the indirect effects of well-
being on HbA1c over time.
We removed individuals with elevated HbA1c or doctor-
diagnosed diabetes from our analytic sample to observe the effects
of HbA1c over time in those who were normo-glycemic at base-
line. Our results still showed a steady increase in HbA1c over time
which is in line with previous research showing an age gradient
(Pani et al., 2008). Over the 8 years follow-up, our participants
showed a mean increase in HbA1c of 4.46 mmol/mol. Coupled
with the high levels of overweight and obesity observed in our
ELSA sample, and the lack of evidence for a reduced risk of dia-
betes among metabolically healthy obese adults (Bell et al., 2014),
these results indicate the need for targeted risk-reduction inter-
ventions in this population age group.
Subjective wellbeing has been associated with incident disease
risk in previous studies (Okely and Gale, 2016) including diabetes
(Boehm et al., 2015). Moreover, a study using data from the
MIDUS 2 cohort (Tsenkova et al., 2016) studied those with a fam-
ily history of diabetes and found that positive affect was protective
against the onset of diabetes in this high risk group. Our results in
initial models were supportive of this trend, revealing wellbeing to
be associated with the underlying biological indicator of disease,
blood glucose, as indicated by HbA1c. Specifically, we found
that a 1-point increase in CASP-19 scores was associated with a
0.035 mmol/mol reduction in HbA1c, indicating a beneficial
effect for higher wellbeing for future HbA1c. While this may
appear to be a rather small effect, given HbA1c is used to define
diabetes on the basis of a cut-off (48 mmol/mol), even small
changes could have clinically meaningful benefits, particularly
among those participants who are close to the upper limits of
normo-glycaemia. Another study using data from MIDUS 2
examined the association between positive wellbeing and cardio-
metabolic risk factors, including HbA1c; post-hoc analyses
revealed no significant effect of life satisfaction or positive emo-
tions on HbA1c 8–11 years later (Boehm et al., 2015). Our find-
ings may differ from those reported by Boehm due to differences
in study design; for example, we excluded those with diabetes and
probable diabetes (HbA1c >48 mmol/mol) at baseline from our
analyses. Previous work has found evidence of an age effect in
the relationship between wellbeing on incident diabetes (Okely
and Gale, 2016) and our findings corroborate this, with wellbeing
predicting HbA1c in younger (<65 years) but not older adults.
Moreover, we found that the CASP-19 dimension of autonomy
was particularly relevant for HbA1c; this subscale reflects the
extent to which an individual feels limited in doing the things
they want to do by factors such as family responsibilities, health
and finances. While the reason for this is not clear, it might sug-
gest a role for stress more generally exerting an influence on
HbA1c (Hackett and Steptoe, 2017). For example, financial strain
(Niedzwiedz et al., 2017) is known to have a detrimental impact
on HbA1c. The association between wellbeing and HbA1c levels
was further examined by taking into account other factors that
might account for the excess risk of elevated HbA1c attributable
to lower wellbeing.
Sociodemographic factors were highlighted in the Alameda
County Study in which mean income over the course of 29
years was positively associated with psychological wellbeing
(Kaplan et al., 2008). In our study, income was positively asso-
ciated with scores on the CASP-19 which considers an indivi-
dual’s sense of control, their sense of autonomy and
self-realization and the amount of pleasure they are able to derive
from their life circumstances; in this way, it can be seen as a global
measure of wellbeing. Previous work has also shown that socio-
economic position is associated with metabolic factors including
HbA1c (Steptoe et al., 2007; Niedzwiedz et al., 2017), as well as
diabetes incidence (Maty et al., 2005). To date, only one previous
study has examined the relationship between wellbeing, socio-
economic status, and HbA1c showing that wellbeing moderates
the association between socioeconomic status and HbA1c
(Tsenkova et al., 2007). Our study adds to this literature by sug-
gesting that the association between lower wellbeing and greater
HbA1c levels over in time can in part be explained by differences
in wealth, and to a lesser extent other factors such as ethnicity and
cohabitation.
There is evidence from some good-quality studies that ethnic
differences in HbA1c exist (Herman et al., 2007), while other
research has described ethnic and cultural differences in the
reporting of mood symptoms (Williams et al., 2015). Our study
found a small (B = −0.296) but non-significant effect of ethnicity
on HbA1c, perhaps in part attributable to the lack of diversity in
our sample. A recent investigation of HbA1c levels in Caucasian
and South Asian adults taking part in the Health Survey for
England showed that ethnic difference in HbA1c was mediated
by positive wellbeing (Umeh, 2018). Other previous work suggests
that ethnic differences in diabetes incidence are not purely attrib-
utable to income disparities, with factors such as differences in
health behaviors including diet, obesity, smoking, and physical
activity (Gujral et al., 2013) also being relevant.
There is growing evidence for the role of behavioral factors for
both diabetes risk factors, such as central obesity, and diabetes
incidence. Obesity has long been established as a primary risk fac-
tor for type 2 diabetes (Mokdad et al., 2003) and is also associated
with increased risk of depression (Luppino et al., 2010) and lower
psychological wellbeing; this latter association is thought in part
to be attributable to weight-related discrimination (Jackson
et al., 2015). Smoking has been established as a risk factor for
type 2 diabetes incidence in a meta-analysis of over 1.2 million
participants (Willi et al., 2007). Moreover, there is also cross-
Fig. 2. The trajectory of HbA1c over time by wave 2 wellbeing status (CASP-19) (N =
1744). N.B. Bars indicate standard error of the mean. Age- and sex-adjusted model.
HbA1c, glycated hemoglobin.
6 Lydia Poole et al.
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0033291719001879
Downloaded from https://www.cambridge.org/core. UCL, Institute of Education, on 02 Sep 2019 at 12:22:07, subject to the Cambridge Core terms of use, available at
sectional evidence that, contrary to popular belief, smokers are
less happy than ex-smokers and non-smokers (Shahab and
West, 2012). The association between alcohol consumption and
diabetes risk follows a U-shaped trend whereby moderate con-
sumption is thought to be protective (Koppes et al., 2005); our
study was unable to examine the units of alcohol consumed but
rather took into account the frequency of consumption.
Physical activity is strongly associated with subjective wellbeing;
for example, baseline psychological wellbeing has been found to
predict higher levels of physical activity over 11 years (Kim
et al., 2017). Other evidence using data from NHANES suggests
a dose–response association between physical activity and
HbA1c levels over time (Gay et al., 2016), which is consistent
with the linear association we report here. Indeed, a systematic
review concluded that the relative risk of type 2 diabetes was
0.69 (95% CI 0.58 to 0.83) for those adults participating in regular
moderate intensity physical activity as compared to being seden-
tary (Jeon et al., 2007). Overall, our findings are largely supportive
of previous research in this field lending support for the link
between wellbeing and HbA1c via the role of health behaviors.
However, future studies are needed to investigate the role of
other mechanisms linking wellbeing with future HbA1c. For
example, there is a large literature demonstrating stress biology
is implicated in the pathophysiology of type 2 diabetes (Hackett
and Steptoe, 2017).
Health behaviors are amenable to change and in particular,
physical activity interventions have been shown to be efficacious
in improving glycemic control. For example, a meta-analysis of
randomized controlled trials assessing the associations between
structured exercise programs on the change in HbA1c in type 2
diabetes patients found that structured exercise training that con-
sists of aerobic exercise, resistance training, or both was associated
with reductions in HbA1c in type 2 diabetes (Umpierre et al.,
2011). There is also evidence of physical activity as a
risk-reduction factor for incident diabetes (Hawley and Lessard,
2008). Further work is needed to look at the longitudinal effects
of such interventions.
A large body of evidence indicates that depression (from
depressive symptoms to clinical depression) predicts new-onset
type 2 diabetes (Knol et al., 2006; Mezuk et al., 2008; Rotella
and Mannucci, 2013). Our results found conflicting evidence to
these studies; we found that lower depressive symptoms were
associated with greater HbA1c over time. These findings are
also in line with our previous work in ELSA in which we report
depressive symptoms are not associated with incident diabetes
(Poole and Steptoe, 2018). Kivimaki et al. (2009) reported in
Table 2. The longitudinal association between wave 2 wellbeing (CASP-19) total score and wave 6 HbA1c using linear regression (N = 2161)
Model
95% CI for B
B S.E. Lower Upper Β p
CASP-19 −0.035 0.012 −0.060 −0.011 −0.053 0.005
CES-D −0.116 0.058 −0.230 −0.002 −0.038 0.046
Sex 0.083 0.175 −0.261 0.427 0.008 0.636
Age −0.006 0.011 −0.029 0.016 −0.009 0.597
Wave 2 HbA1c 0.973 0.023 0.927 1.019 0.673 <0.001
B, unstandardized regression coefficient; β, standardized regression coefficient; CES-D, Center for Epidemiological Studies Depression (CES-D) scale; CI, confidence interval; HbA1c, glycated
hemoglobin; S.E., standard error.
Table 3. The longitudinal association between wave 2 wellbeing (CASP-19) total score and wave 6 HbA1c in linear regression models following adjustment for
covariates (N = 2161)
Model
95% CI for B
B S.E. Lower Upper Β p β % changeb
1. Basic modela −0.035 0.012 −0.060 −0.011 −0.053 0.005 –
2. Model 1 + wealth, ethnicity, cohabitation −0.029 0.013 −0.054 −0.004 −0.044 0.022 16.98%
3. Model 1 + BMI, regular alcohol, smoking, physical activity −0.027 0.013 −0.051 −0.002 −0.040 0.035 24.53%
4. Model 1 + CHD, stroke, hypertension, β-blockers −0.034 0.013 −0.058 −0.009 −0.051 0.007 3.77%
5. All −0.024 0.013 −0.049 0.001 −0.036 0.064 32.08%
B, unstandardized regression coefficient; β, standardized regression coefficient; BMI, body mass index; CES-D, Centre for Epidemiological Studies Depression Scale; CI, confidence interval;
HbA1c, glycated hemoglobin; S.E., standard error.
All covariates were measured at wave 2 baseline.
aAdjusted for CED-D score, age, sex, baseline HbA1c.
bPercentage change in β for CASP-19 in relation to the basic model.
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cross-sectional analyses that there is a U-shaped association
between blood glucose and depressive symptoms, such that ele-
vated depressive symptoms are observed at both low and high glu-
cose levels; however, this has not been supported by others (Gale
et al., 2010). The complexity of the association has increased fur-
ther by findings which suggest antidepressant use is associated
with the incidence of diagnosed diabetes, but not undiagnosed
diabetes nor with fasting or 2 h post-load plasma glucose levels
or increasing glucose levels over time (Kivimäki et al., 2011); a
similar trend using data from NHANES has also been reported
(Mezuk et al., 2013). These results suggest the link between
depression and diabetes may in part be attributable to clinical
ascertainment bias (Kivimäki and Batty, 2015). Nevertheless,
our study looked at the effect of subjective wellbeing on later
HbA1c, while taking into account baseline depressive symptoms,
and the results were upheld; our findings are supportive of an
independent effect of positive affect over and above the role of
negative mood states. We did not study reverse causation in this
study, though there is evidence that HbA1c levels are associated
with future depressive symptoms (Hamer et al., 2011). The nature
of the bi-directional relationship between affect and glycemic con-
trol warrants investigation in future studies using measures of
positive wellbeing.
There are several advantages to our study. First, we used data
from a nationally representative cohort study of older adults with
longitudinal, repeated measures, allowing us to track changes in
HbA1c over time. HbA1c and BMI were both objectively mea-
sured rather than self-reported. We had a large sample of partici-
pants and were able to take into account a diverse array of
covariates in our models. However, some limitations also need
to be borne in mind. Unfortunately, due to funding constraints,
HbA1c data at wave 8 was only collected in a small subset of
the ELSA cohort, restricting the length of follow-up. Subjective
wellbeing was measured using a questionnaire measure and
does not take into account other aspects of positive affect such
as optimism; similarly, depressive symptoms were only captured
using a short questionnaire measure. Behavioral factors such as
physical activity were also self-reported and future studies
would benefit from the use of objective measures such as via
the use of accelerometers. Diet information was not included in
ELSA at wave 2, but future studies would benefit from
investigating the role of nutrition in these pathways. Moreover,
ELSA is a predominately comprised of participants of white eth-
nic origin, limiting the generalizability of our findings to other
groups.
In conclusion, our results indicate that subjective wellbeing
may exert protective effects against disease, via its role in glucose
metabolism and underlying diabetes pathology. We showed that
the association between subjective wellbeing and greater HbA1c
over 8 years of follow-up was in part attributable to sociodemo-
graphic, behavioral, and clinical factors. Future work is needed
to explore the use of interventions in individuals with lower well-
being to help reduce HbA1c levels.
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